Record number:
309
Adverse Occurrence type:
MPHO Type:
Estimated frequency:
Most recent risk assessment (Council of Europe, 2022): Oesophageal, gastric, pancreatic, liver and biliary cancers diagnosed during donor procurement : These tumours are classified as unacceptable risk. Oesophageal, gastric, pancreatic, liver and biliary cancers in the donor history: Treated tumours of these kinds in the donor history are classified as high risk due to their aggressive behaviour. Risk may decrease for early stages after curative therapy, with recurrence-free time > 5 years and with increasing probability of cure, especially in cases of long-term survivors
Time to detection:
12 months
Alerting signals, symptoms, evidence of occurrence:
Not specified. Diagnosed 12 months after Tx. Alive after retransplantation.
Demonstration of imputability or root cause:
Not specified.
Imputability grade:
2 Probable
Groups audience:
Keywords:
Suggest new keywords:
liver transplant
registry series
malignancy
Reference attachment:
Suggest references:
aaa
Expert comments for publication:
Presumed transmitted, but no data given as this was part of a registry report